… Adenosine is a potent vasodilator of coronary arterioles and can be safe, but has … grafting
(CABG) in SAVR recipients originates from observational studies in which patients undergoing …

… a patient-centric approach to guide clinicians in the treatment of patients with significant
coronary artery disease undergoing … CABG is more often chosen in patients undergoing CABG …

… for patients with coronary artery disease. Importantly, … The potent anti-inflammatory and
antiplatelet effects of ticagrelor … predominant method of coronary bypass grafting performed at our …

… ) surgery still is the best treatment for multi-vessel and left … cant prognostic factors for CAD
patients undergoing CABG surgery… The potent platelet inhibitory effects of S-nitrosated albumin …

… in stable CAD. • PFT to escalate treatment (switch to potent antiplatelet drugs) in patients with
… Finally, genetic variants are just 1 influential factor affecting clopidogrel activity; numerous …

… by-pass graft (CABG) techniques and more potent antiplatelet … independent risk factor for
the development of CAD. Coronary … Recent data on diabetic patients undergoing PCI revealed …

… grafting (CABG) is still considered the gold standard for patients with extensive Coronary Artery
Disease in … It is the positive isomer that is predominantly responsible for the potent β1and …

… for treating coronary artery disorders (CAD) is coronary artery bypass graft surgery (CABG). …
lifestyle norms, a potent factor promising improved quality of life post coronary artery bypass …

… Coronary artery bypass grafting (CABG) is the most effective treatment for multivessel … and
progression of CAD (4, 5). When performing surgical revascularization, potent inflammatory …

… the patient profile, treatment, and follow-up of premature CAD … arterial coronary bypass graft
(CABG), and potent secondary … This was also true for patients who underwent CABG surgery …